ESBL-Producing Salmonella enterica Serovar Typhi in Traveler Returning from Guatemala to Spain
暂无分享,去创建一个
I. Molina | F. Salvador | A. Sánchez-Montalvá | A. Planes | M. Larrosa | N. Piedra-Carrasco | J. González-López | Virginia Rodríguez
[1] C. Chiu,et al. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan. , 2013, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[2] A P MacGowan,et al. EUCAST expert rules in antimicrobial susceptibility testing. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[3] K. Nahar,et al. Salmonella enterica serovar Typhi strain producing extended-spectrum β-lactamases in Dhaka, Bangladesh. , 2012, Journal of medical microbiology.
[4] Zhemin Zhou,et al. Multilocus Sequence Typing as a Replacement for Serotyping in Salmonella enterica , 2012, PLoS pathogens.
[5] Song Gao,et al. Prevalence of qnr, aac(6′)-Ib-cr, qepA, and oqxAB in Escherichia coli Isolates from Humans, Animals, and the Environment , 2012, Antimicrobial Agents and Chemotherapy.
[6] James R. Johnson,et al. Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration. , 2010, International journal of antimicrobial agents.
[7] W. Rabsch,et al. Salmonella enterica Serovar Typhi with CTX-M β-Lactamase, Germany , 2009, Emerging infectious diseases.
[8] M. Albert,et al. Emergence of CTX-M-15 type extended-spectrum beta-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. , 2008, Journal of medical microbiology.
[9] P. Savelkoul,et al. Extended-Spectrum-Beta-Lactamase Production in a Salmonella enterica Serotype Typhi Strain from the Philippines , 2008, Journal of Clinical Microbiology.
[10] G Prats,et al. Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain. , 2008, The Journal of antimicrobial chemotherapy.
[11] V. Miriagou,et al. Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. , 2004, International journal of antimicrobial agents.
[12] J. Crump,et al. The global burden of typhoid fever. , 2004, Bulletin of the World Health Organization.
[13] Mark Achtman,et al. Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000 years old. , 2002, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[14] A. Brisabois,et al. Comparative Studies of Mutations in Animal Isolates and Experimental In Vitro- and In Vivo-Selected Mutants ofSalmonella spp. Suggest a Counterselection of Highly Fluoroquinolone-Resistant Strains in the Field , 1999, Antimicrobial Agents and Chemotherapy.
[15] A. B. CiusnE,et al. Typhoid fever. , 1967, The Journal of the Arkansas Medical Society.